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The prevalence of pathogenic multi-drug resistant (MDR) extended-spectrum
β-lactamase (ESBL)-producing Escherichia coli is rapidly increasing, becoming a
global concern. In a veterinary context, ESBL-producing E. coli are mostly reported in
poultry and pigs. Here, we report on the prevalence and characterize ESBL-producing
E. coli isolated from diverse dairy farms in China. Overall, 36 (23.53%) out of 153 E. coli
isolates from mastitic milk samples (n = 1252) were confirmed as ESBL-producers by
double-disc synergy testing and PCR. Nucleotide analysis of PCR amplicons revealed
that blaCTX-M was the predominant ESBL gene detected in 28 (77.78%) isolates, with
blaCTX-M-15 being the major (78.57%) allele encoding for ESBLs. Also, 20 (55.56%) and
6 (16.67%) of the ESBL isolates were carrying blaTEM and blaSHV genes, respectively,
in singlet or in combination. The majority of these isolates belonged to phylo-group
A (69.44%) and D (16.67%). Strikingly, all these isolates were found to be MDR
showing high resistance to cephalosporins including the fourth generation cefepime and
common non β-lactams. Additionally, class 1 integrons (intI1) were found in 30 (83.33%)
isolates. Analysis of the class 1 integrons variable regions indicated that they were
carrying up to five different gene cassettes conferring resistance to various drugs with
a predominant combination of dfrA17-aadA5 genes in tandem, conferring resistance
to aminoglycosides and trimethoprim. However, no ESBL encoding genes were found
in the cassettes. Interestingly, 22 (66.11%) of the ESBL isolates were also carrying
insertion sequence common region 1 (ISCR1) which was found to be associated with
most of the CTX-M genes. Altogether, the current study reports on the high prevalence
of ESBL-positive E. coli, particularly CTX-M-15, carrying clinical class 1 integrons and
ISCR1 elements are likely indicative of their rapid and wider dissemination, posing
threats to veterinary and public health. To the best of our knowledge, this is the first
comprehensive study to report on the alarming high occurrence of ESBL-producing
E. coli from mastitic cows in China.
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INTRODUCTION
Bovine mastitis, inflammation of the mammary gland, is the
most prevalent and economically important disease of dairy
animals (Halasa et al., 2007). Mastitis can be caused by a
variety of bacterial pathogens, but Escherichia coli is one of
the leading causes (Dahmen et al., 2013). Antimicrobial agents
are used for therapeutic as well as preventive measures against
bacterial infections including bovine mastitis in farm animals.
Beta-lactams, such as ampicillin and amoxicillin, remain the
first-line treatment in veterinary medicine but an increase
in drug-resistance to these antibiotics has been observed.
Therefore, extended-spectrum cephalosporins (ESC) such as
ceftiofur have been approved in China for the treatment of animal
diseases (MAO, 2010). Unfortunately, several recent studies have
reported the increasing occurrence of highly resistant extended-
spectrum β-lactamase (ESBL)-producing Enterobacteriaceae,
mainly E. coli, isolated from food-producing animals from
various countries including China (Rao et al., 2014; Xu et al.,
2015; Seni et al., 2016).
Bacterial resistance to β-lactams, popular antibiotics due to
their proven safety and efficiency, is increasing at an alarming
rate. This resistance is mainly achieved through β-lactamases
that can hydrolyse most β-lactam antibiotics including the
third and fourth generation ESCs and monobactams (Bush
and Jacoby, 2010). ESBLs are predominantly produced in gram
negative bacteria, particularly in E. coli, and are considered
a key mechanism conferring resistance to cephalosporins
(Perez et al., 2007). Multi-drug resistance (MDR) has been
commonly observed in most ESBL-producers and more
alarmingly, co-resistance to other commonly used antibiotics
like aminoglycosides, fluoroquinolones, tetracycline has been
often reported (Chen et al., 2010; Timofte et al., 2014; Xu et al.,
2015). This renders these organisms resistant to a wide range
of antibiotics with limited therapeutic options. ESBL encoding
genes have been categorized into three main types: blaCTX-M,
blaSHV, and blaTEM. The blaCTX-M has been further categorized
into five sub-groups (blaCTX-M-1, blaCTX-M-2, blaCTX-M-8,
blaCTX-M-9, blaCTX-M-25) and more than 150 variants have
been documented (http://www.lahey.org/studies). In the past
few years, CTX-M, especially CTX-M-15, has emerged as the
most dominant type of ESBLs globally (D’Andrea et al., 2013).
Recently, CTX-M-15 producing E. coli have been frequently
documented from various sources including humans and food
producing animals (Timofte et al., 2014; Liu et al., 2015; Xu
et al., 2015), showing the broad spectrum of reservoirs carrying
and spreading these genes. Food-animals are well established
reservoirs of ESBL-producing E. coli, which can be transmitted
from animals to humans by various direct and indirect means
(Dahmen et al., 2013; Geser et al., 2015). This is also verified by
Madec et al. (2012), they reported that the plasmids carrying
CTX-M-15 genes in E. coli isolated from cattle were highly
similar to those found in ESBL-producing E. coli isolates from
human beings.
Integrons are genetic elements that play a vital role in the
development and dissemination of MDR in clinical isolates
due to their ability to capture, integrate and express gene
cassettes (Vinue et al., 2008; Chen et al., 2010). Three main
classes of integrons (1–3), carrying the gene cassettes encoding
for antimicrobial resistance genes, are generally found to be
associated with antibiotic resistance genes in pathogenic E. coli,
Class 1 integrons are the most common in clinical E. coli,
followed by less frequent class 2 integrons (Vinue et al., 2008; Xu
et al., 2015). Class 1 integrons contain a 5′ conserved segment
(CS) and 3′CS, followed by a variable region that contains one
or more gene cassettes. The 5′CS consists of an integrase gene
(intI1), a recombination-site (attI1), and the Pc promoter(s),
and the 3′CS includes qacE∆1 and sul1 genes which encode for
quaternary ammonium compound and sulphonamide resistance
(Hall and Stokes, 1993). Moreover, insertion sequences like
ISCR1 (insertion sequence common region 1) as part of the
complex class 1 integrons are found to be associated with ESBL
and other resistance encoding genes and are probably involved
in their mobilization and transposition. ISCR1 may mobilize the
truncated 3′CS and nearby sequences from one integron to the
3′CS of another integron utilizing rolling circle transposition,
thus facilitating dissemination of resistance elements (Eckert
et al., 2006; Toleman et al., 2006).
Limited studies, particularly from China, have characterized
ESBL-producing E. coli isolated from diseased food producing
animals, mainly from mastitic cows (Lu et al., 2010; Timofte
et al., 2014). Thus, we designed the current study to investigate
the prevalence of pathogenic ESBL-producing E. coli and to
characterize the ESBL genes and genetic elements which are likely
to be responsible for theirmobility and dissemination. To the best
of our knowledge, this is the first comprehensive study into the
molecular characterization of ESBL genes in E. coli isolated from
dairy cows in China.
MATERIALS AND METHODS
Statement of Ethics
The present study was conducted in accordance with the
ethical guide lines of China Agricultural University (CAU),
Beijing. Proper ethical approval was granted by the departmental
committee of College of Veterinary Medicine, CAU. Sampling
was carried according to the standard protocols and with prior
consent of the dairy herd’s authority.
Sample Collection and Location
Milk samples of mastitic cows (n = 1252) were collected
from 61 large commercial dairy herds (2000–40,000 cows/herd)
located in 16 provinces of China during January 2015 to
May 2016 (Figure 1 and Table 1). Sampling was carried out
when the cows were suffering from mastitis and not according
to a fixed schedule. The guidelines of the National Mastitis
Council (NMC, 1999) were followed for the collection of milk
samples from cows. Samples were taken in 50 mL sterile
tubes and transported on ice to the laboratory for further
processing.
Isolation and Identification of E. coli
Milk samples, shortly after arrival, were streaked (10 µL) onto
MacConkey Agar (DifcoTM, Becton Dickinson, Sparks, MDUSA)
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FIGURE 1 | Map of China (mainland) showing 16 provinces from where samples were collected.
and incubated at 37◦C for 18–24 h. Presumptive E. coli colonies
with the dark pink to red colors, were further confirmed with
the API-20E kit (bioMérieux, Marcy I’Etoile, France) as per
instruction of the manufacturer. Biochemically confirmed E. coli
isolates were further verified by PCR as described previously
(Tantawiwat et al., 2005). Confirmed E. coli isolates were stored in
brain heart infusion broth (BHI; Sigma-Aldrich) containing 30%
glycerol at−80◦C.
Phenotypic Screening of ESBL-Producers
E. coli isolates were first screened for the phenotypic
identification of ESBLs-producers on MacConkey agar
containing cefotaxime (1 mg/L). These presumptive ESBL-
producing E. coli were further confirmed by double-disc synergy
testing in accordance with recommendations of the Clinical and
Laboratory Standards Institute (CLSI, 2014), using antimicrobial
discs (Becton Dickinson, Sparks, MD USA) of cefotaxime (30
µg), cefotaxime plus clavulanic acid (30/10 µg), ceftazidime
(30 µg), and ceftazidime plus clavulanic acid (30/10 µg). The
test was recorded positive when the zone of inhibition of
cefotaxime plus clavulanic acid or ceftazidime plus clavulanic
acid was ≥5 mm larger than their respective single discs (CLSI,
2014).
Genotypic Screening of ESBL-Producing
E. coli Isolates
Bacterial DNA from ESBL-positive E. coli was isolated by
the TIANamp Bacteria DNA Kit (TIANGEN, Beijing, China)
according to the manufacturer’s instructions. PCR assays were
used for the detection of blaCTX-M,blaSHV, blaTEM genes as
described previously (Chen et al., 2010). Details of the primers
used in this study are shown in Table 2. All ESBL genes
relevant PCR amplicons were purified by the TIANquick Midi
Purification Kit (TIANGEN, Beijing, China), bi-directionally
sequenced and aligned with sequences available in GenBank
(Chen et al., 2010). Klebsiella pneumoniae ATCC 700603 (ESBLs-
positive strain) and ddH2O, instead of template DNA, was
used as positive and negative controls, respectively, in all PCR
assays.
Phylogenetic Grouping
ESBL-positive E. coli isolates were placed in one of the four
phylogenetic groups: phylo-group A, group B1, group B2 or
group D. For this purpose, a triplex PCR assay targeting the chuA
and yjaA genes and TspE4 was used as described previously by
Clermont et al. (2000). The primers sequences and the annealing
temperatures are listed in Table 2.
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TABLE 1 | Occurrence of ESBL-producing E. coli isolated from dairy herds located in 16 provinces of China.
Provinces of sampling No. of dairy herdsa No. of milk samplesb E. coli
isolatesc
ESBL E. coli from
each herdd
Anhui A 63 4 0
Beijing B/B1/B2 26 (6/9/11) 5 (2/2/1) 0/0/0
Fujian F 12 0 0
Guangdong G/G1 98 (23/75) 3 (1/2) 2 (0/2)
Hebei Hb/ Hb1/ Hb2/ Hb3 220 (11/10/16/16 36 (2/0/0/5 2 (0/0/0/1
/Hb4/Hb5/Hb6/Hb7
/Hb8/Hb9/Hb10
/6/11/12/18/23
/24/12/38/14/9)
/1/0/0/4/5
/3/3/6/6/1)
/0/0/0/0/1
/0/0/0/0/0)
/Hb11/Hb12/Hb13
Heilongjiang H/H1/H2/H3 73 (10/13/10/40) 7 (4/2/0/1) 1 (1/0/0/0)
Henan Hn/Hn1/Hn2/Hn3/Hn4 43 (12/6/7/12/6) 5 (2/0/0/2/1) 4 (2/0/0/2/0)
Inner-Mongolia I/I1/I2/I3/I4/I5 425 (17/14/12/18 45 (1/2/0/1 23 (0/0/0/0
/I6/I7/I8/I9/I10 /42/37/49/22/24 /6/8/7/5/3 /5/7/6/3/0
/I11/I12/I13 /61/33/53/22/21) /6/0/3/2/1) /2/0/0/0/0)
Jiangsu J 9 4 2
Liaoning L 20 4 1
Ningxia N/N1/N2/N3 97 (15/32/20/30) 19 (2/7/5/5) 1 (0/1/0/0)
Shaanxi Sx-Bj 13 2 0
Shandong S/S1/S2/S3 83 (14/14/15/40) 8 (0/1/5/2) 0/0/0/0
Shanxi Sx-Cz 6 0 0
Shanghai S/S1/S2/S3 59 (16/16/10/17) 10 (1/0/6/3) 0/0/0/0
Tianjin T 5 1 0
Total 61 1252 153 (12.22%) 36 (23.53%)
aThe letters in the column represent the farm number.
bThe numbers in parenthesis indicate no. of milk samples corresponding to the respective farm in second column.
cThe numbers in parenthesis show E. coli isolates from the respective farm.
dThe numbers in parenthesis indicate ESBL-producing E. coli isolated from the respective farm.
Antibiotic Susceptibility Testing
Antibiotic susceptibility of ESBL isolates was carried out on
Mueller-Hinton agar (DifcoTM) against 16 different antibiotics
discs (Becton Dickinson, Sparks, MD, USA), using the
standard Kirby-Bauer disk diffusion method according to
recommendations of the CLSI (2014). The panel of antimicrobial
agents consisted of both β-lactam and non-β-lactam antibiotics
as listed in Table 3. E. coli ATCC 25922 (ESBL-negative
strain) and K. pneumoniae ATCC 700603 (ESBL-positive
strain) were used as quality control strains (CLSI, 2014). The
isolates were declared as multi-drug resistant (MDR) when
found resistant to three or more categories of antimicrobial
drugs.
Detection of Integrons, Gene Cassettes
and ISCR1
A PCR assay was used to detect Class 1, 2, and 3 integrons
in all ESBL-producing E. coli using integron-integrase gene
specific primers, intI1, intI2, and intI3, respectively (Dillon et al.,
2005). Subsequently, the intI1 positive genotypes (n = 24) were
determined by sequencing amplicons derived from PCR for
the class 1 integron variable regions as described previously
(White et al., 2000). The ISCR1 region was PCR amplified from
ESBL-producing isolates using specific primers (Table 2). The
sequenced amplicons of the ISCR1 elements were confirmed by
BLAST analysis (see below). A combination of primers specific
to the ISCR1 elements (Kiiru et al., 2013) elements and consensus
primers of ESBL genes were used to verify their association.
PCR-RFLP Genotyping of Class 1 Integron
Variable Region Amplicons
A PCR-based restriction fragment length polymorphism (PCR-
RFLP) assay was adopted to identify genetic variation in the
amplified products using restriction enzymeHinfI (Takara, Shiga
Japan) as published previously (Gu et al., 2008). PCR-RFLP
products with similar band profiles were regarded as the same
genotypes carrying identical gene cassette(s).
Nucleotide Sequencing and Data Analysis
Regardless of the similar PCR-RFLP genotypes, all amplicons
of gene cassettes, ISCR1 elements, and ESBL genes were bi-
directionally sequenced using ABI 3730 sequencer (Applied
Biosystems, Foster City, CA, USA). PCR amplicons of >1.8
kb were further sequenced using primer walking based on the
sequenced amplicons. The obtained sequences were subjected to
BLAST homology searches in the INTEGRALL database (http://
integrall.bio.ua.pt). Other sequence analyses were compared
with BLASTN software (http://www.ncbi.nlm.nih.gov/BLAST/).
Clone Manager 7 (Sci-Ed software, Denver, USA) and ClustalW2
(http://www.ebi.ac.uk/Tools/msa/clustalw2/) were also used for
detailed analysis such as alignments and open reading frames.
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TABLE 2 | Details of primers used in this study.
Primers Sequence (5′ to 3′) Target gene Annealing Amplicons References
temperature size
β-lactamases
CTX-MA
CTX-MB
CGC TTT GCG ATG TGC AG
ACC GCG ATA TCG TTG GT
blaCTX-M 54
◦C 550-bp Villegas et al., 2004
SHV-F
SHV-R
GGG TTA TTC TTA TTT GTC GC
TTA GCG TTG CCA GTG CTC
blaSHV 58
◦C 567-bp Chang et al., 2001
TEM-F
TEM-R
ATA AAA TTC TTG AAG ACG AAA
GAC AGT TAC CAA TGC TTA ATC
blaTEM 56
◦C 1086-bp Yao et al., 2007
INTEGRONS
intI1-F CCT CCC GCA CGA TGA TC intI1 54◦C 280-bp Dillon et al., 2005
intI1-R TCC ACG CAT CGT CAG GC
intI2-F AAA TCT TTA ACC CGC AAA CGC intI2 54◦C 439-bp Dillon et al., 2005
intI2-R ATG TCT AAC AGT CCA TTT TTA AAT TCT A
intI3-F AGT GGG TGG CGA ATG AGT G intI3 54◦C 599-bp Dillon et al., 2005
intI3-R TGT TCT TGT ATC GGC AGG TG
intI1-VR-F TCA TGG CTT GTT ATG ACT GT intI1variable region 56◦C variable White et al., 2000
ntI1-VR-R GTA GGG CTT ATT ATG CAC GC
E. coli-SPECIFIC
UAL TGG TAA TTA CCG ACG AAA ACG GC uidA 62◦C 147-bp Tantawiwat et al., 2005
UAR ACG CGT GGT TAC AGT CTT GCG
PHYLO-GROUPS
ChuA-F GAC GAA CCA ACG GTC AGG AT ChuA 55◦C 279-bp Clermont et al., 2000
ChuA-R TGC CGC CAG TAC CAA AGA CA
YjaA-F TGA AGT GTC AGG AGA CGC TG YjaA 55oC 211-bp Clermont et al., 2000
YjaA-R ATG GAG AAT GCG TTC CTC AAC
TspE4C2-F GAG TAA TGT CGG GGC ATT CA TspE4C2 55◦C 152-bp Clermont et al., 2000
TspE4C2-R CGC GCC AAC AAA GTA TTA CG
ISCR1
ISCR1-F
ISCR1-R
CGC CCA CTC AAA CAA ACG
GAG GCT TTG GTG TAA CCG
ISCR1 55◦C 469-bp Kiiru et al., 2013
F, forward; R, reverse.
TABLE 3 | Antibiotic susceptibility profiles of ESBL-producing E. coli isolates (n = 36) from milk of mastitic cows.
Antimicrobial agents Abbreviations Conc.* (µg) Susceptible (%) Intermediate (%) Resistance (%)
Ampicillin AM 10 11.11 (04/36) 02.78 (01/36) 86.11 (31/36)
Amoxicillin/clavulanic acid AMX/CA 20/10 25.00 (9/36) 11.11 (04/36) 63.89 (23/36)
Cefalexin CX 30 00.00 (00/36) 00.00 (00/36) 100 (36/36)
Cefaclor CEC 30 05.56 (02/36) 00.00 (00/36) 94.44 (34/36)
Cefoxatin FOX 30 83.34 (30/36) 08.33 (03/36) 8.33 (3/36)
Cefotaxime CTX 30 00.00 (00/36) 00.00 (00/36) 100.0 (36/36)
Ceftazidime CAZ 30 33.33 (12/36) 00.00 (00/36) 66.67 (24/36)
Cefepime FEP 30 41.67 (15/36) 11.11 (04/36) 47.22 (17/36)
Aztreonam AZT 30 13.89 (05/36) 00.00 (00/36) 86.11 (31/36)
Meropenem MPN 10 100.0 (36/36) 00.00 (00/36) 00.00 (00/36)
Tetracycline TE 30 16.67 (06/36) 11.11 (04/36) 72.22 (26/36)
Gentamicin G 10 27.78 (10/36) 11.11 (04/36) 61.11 (22/36)
Ciprofloxacin CIP 05 55.56 (20/36) 08.33 (03/36) 36.11 (13/36)
Chloramphenicol C 30 47.22 (17/36) 11.11 (4/36) 41.67 (15/36)
Nalidixic acid NAL 30 19.44 (07/36) 02.78 (01/36) 77.78 (28/36)
Trimethoprim/sulphamethoxazole STX 1.25/23.75 25.00 (09/36) 02.78 (01/36) 72.22 (26/36)
*Conc: concentrations.
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RESULTS
Prevalence and Characterization of
ESBL-Producing E. coli
Overall, 153 E. coli isolates were recovered from 1252 milk
samples of mastitic dairy cows from 16 different provinces
of China. Thirty six (23.53%) isolates were detected as ESBL-
producing E. coli by phenotypic confirmatory tests and this
was also verified by ESBL genotype specific PCR assay. The
distribution of these isolates among different cattle herds is
shown in Table 1. The highest occurrence of ESBL producers was
observed in the Inner Mongolia province (23 isolates), followed
by the Henan region (four isolates).
Figure 2 shows the frequency (%) of various ESBL encoding
genes among 36 ESBL-producing E. coli isolated from mastitic
milk. Overall, blaCTX-M was the most prevalent ESBL gene
(77.78%; 28/36), while blaTEM and blaSHV genes were present
in 55.56% (20/36) and 16.67% (6/36) of ESBL-positive isolates,
respectively. The blaTEM and blaSHV genes were most frequently
observed together with blaCTX-M, rather than alone (Figure 2).
Notably, two of the isolates from Inner Mongolia carried
three β-lactamase genes (blaCTX-M-15+blaTEM-1+blaSHV-12) in
combination. Sequence analysis revealed that blaCTX-M-15
was the dominant (78.57%; 22/28) subtype. The other
blaCTX-Msubtypes were: blaCTX-M-14 (10.71%; 3/28), blaCTX-M-1
(3.57%; 1/28), blaCTX-M-3(3.57%; 1/28), and blaCTX-M-55 (3.57%;
1/28). The phylo-group Awas themost prevalent (69.44%; 25/36)
among 36-ESBL-positive E. coli followed by group D (16.67%;
6/36), B1 (8.33%; 3/36), and B2 (5.56%; 2/36) as depicted in
Table 4.
Antibiotic Susceptibility Profiles
All 36 ESBLs-producing E. coli isolates were found to be
multiple-drug resistant (MDR). However, different isolates
exhibited slight variation in their antibiotic susceptibility profiles
against the 16 tested antibiotics (Table 3). The majority of
the isolates were resistant to first (cephalexin, 100%), second
FIGURE 2 | Distribution of ESBLs encoding genes and CTX-M subtypes
among ESBL-producing E. coli (n = 36) isolated from bovine mastitis.
(cefaclor, 94.4%), third (cefotaxime and ceftazidime, 100% and
66.67%, respectively), and fourth (cefepime, 58.33%) generation
cephalosporins. However, a high rate of susceptibility was
observed toward cefamycin (cefoxatin, 83.34%) and carbapenem
(meropenem, 100%), but susceptibility to monobactams
(aztreonam, 13.89%) was low. The isolates were also resistant
to other β-lactam and non-β-lactam antibiotics including
ampicillin (88.89%), amoxicillin/clavulanic acid (75.00%),
chloramphenicol (52.78%), ciprofloxacin (44.44%), gentamicin
(72.22%), nalidixic acid (80.56%), tetracycline (83.33%) and
trimethoprim/sulphamethoxazole (75%).
Detection of Integrons, Gene Cassettes
and ISCR1
Thirty (83.33%) of the ESBL-producing E. coli carried clinical
class 1 integrons but class 2 and class 3 integrons were
not detected in any of the isolates. Among the intI1+ESBL-
producing E. coli, 24 (80.00%) isolates tested positive for the
presence of variable regions, while six of the isolates could not
be amplified (Table 4). Furthermore, these 24 isolates were also
positive for qacE∆1/sul1 indicating a complete clinical class 1
integron. Integrons lacking 3′CS were not PCR amplified for
qacE∆1/sul1 (results not shown).
The PCR-amplicon sizes of the inserted gene cassettes ranged
between ∼1.0 and ∼2.2 kb with the most predominant being
∼1.7 kb amplicons (Figure 3). Most of the PCR amplicons of
the variable regions of gene cassette arrays were a single band.
However, two of the isolates produced a double band (of ∼1.7
and ∼ 0.2 kb). Subsequent sequence analysis of the gel extracted
amplicons indicated that the smaller band was nonspecific
amplification. Different band profiles of PCR-RFLP products
indicated five distinct genotypic configurations (Figure 4). The
most predominant PCR-RFLP genotype produced a profile of
∼0.6, ∼0.4, ∼0.45, ∼0.2, and ∼0.22 kb restriction fragments
consistent with digestion of 1.7 kb PCR amplicon of the
variable regions. Amplicons sequence analysis of the variable
regions revealed five gene cassettes carrying single or two genes
in tandem. The predominant combination was dfrA17-aadA5
in tandem that conferred resistance to aminoglycosides and
trimethoprim. Interestingly, all the CTX-15-positive isolates,
except two, carried dfrA17-aadA5 genes in combination. This
was consistent with the antibiotic susceptibility profile of these
isolates reflecting resistance to the relevant drugs (Table 4).
Surprisingly, no ESBL genes were found encoded in the variable
region of the gene cassette array of these isolates. Therefore,
ISCR1 elements were investigated by targeted-PCR. The PCR
amplicons of ISCR1 elements were sequenced and confirmed by
homology. Results indicated that ISCR1was found in 22 (66.11%)
ESBL positive isolates (Table 4). Moreover, ISCR1 (Accession
number KY095113) was found associated with blaCTX-M, blaTEM
and blaSHV in 16, 3, and 4 isolates, respectively. Interestingly,
all blaCTX-M-15 positive isolates, except one (Hn1-6), have
been always found associated with ISCR1 elements. However,
blaTEM, when found alone or in combination with others,
except blaCTX-M-15, was mainly negative for ISCR1 elements. The
amplicon size resulting from PCR using primer combinations
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FIGURE 3 | Detection of class 1 integrons variable regions in
ESBL-producing E. coli. PCR product was separated on 1% agarose gel.
Lane 1, I-3 (intI1+) isolate; Lane 2, I1-8strain; Lane 3, G-2 isolate; Lane 4, H-5
(intI1-ve) isolate; Lane 5, I2-3 E. coli; Lane 6, Hn1-2 strain; Lane 7, positive
control strain; Lane 8, 2K molecular marker (Transgen, Beijing, China).
FIGURE 4 | Restriction fragment length polymorphism (RFLP) analysis
of intI1 variable region amplicons using Hinf I enzyme. RFLP product
was analyzed on 1.5% agarose gel. Lane 1, I-3 isolate; Lane 2, I-25 E. coli;
Lane 3, Hn1-2 isolate; Lane 4, I2-3 isolate; Lane 5, G-2 strain; Lane 6,
Hb3-1isolate; Lane 7, Hn1-7 E. coli strain; Lane 8, 2K molecular marker.
specific to ISCR1 elements and ESBL genes revealed that the
ESBL genes were oriented downstream of ISCR1 elements.
Altogether, these results indicated that ISCR1 elements are
associated with ESBL genes. The detailed characterizations of all
ESBLs-producing E. coli are elaborated in Table 4.
DISCUSSION
In the past few years, ESBL-producing E. coli have been
increasingly isolated from food-producing animals raising global
concerns for veterinary and public health (Seiffert et al., 2013).
The current study reports on the higher occurrence (23.53%) of
ESBL-producing E. coli (n = 36) among 153 E. coli isolates from
mastitic cows, as compared to previous reports from China (Yu
et al., 2015) and other countries (Dahmen et al., 2013; Geser
et al., 2015; Freitag et al., 2016). Interestingly, the majority of
ESBL-producing E. coli (23 isolates) were recovered from herds in
Inner Mongolia province possibly linked to dense farming (2.37
million dairy cows) with the largest dairy herds in this province
(Dou, 2014). Dense farming is significantly correlated with the
incidence of bovine mastitis (Ali et al., 2014), and mastitis is
the main reason for frequent and prolonged use of antibiotics
that exert selective pressure for emergence and dissemination
of resistant isolates (Berge et al., 2005). Our results revealed
that CTX-M, mainly the CTX-M-15, was the most prevalent
genotype, followed by TEM and SHV. These findings agree
with other contemporary studies from China and around the
world that also reported CTX-M as the dominant ESBL genotype
(Locatelli et al., 2009; Dahmen et al., 2013; Geser et al., 2015;
Kar et al., 2015). This goes along with the recent detection
of CTX-M-15 producing E. coli from cattle and other food-
animals in east Asia (Ohnishi et al., 2013; Yu et al., 2015), India
(Upadhyay et al., 2015), the United Kingdom (Timofte et al.,
2014), Germany (Freitag et al., 2016) and Tanzania (Seni et al.,
2016). A national resistance surveillance study in China reported
that the prevalence of ESBL-producing E. coli in humans has
persisted above 50% since 2000 (Xiao et al., 2011), and recently
Liu et al. reported even higher prevalence (68.2%) of ESBLs
in clinical E. coli isolates, mainly the blaCTX-M-15 (Liu et al.,
2015). Similarly, in animals the prevalence of ESBL-producing
E. coli in China has considerably increased in recent years with
CTX-M being the major prevailing gene encoding for ESBLs
(Rao et al., 2014). It is known that, generally, ESBL genes are
located on plasmids that could spread easily among commensal
and pathogenic bacteria in the herd and the environment.
Due to limited resources, in the present study, we could not
investigate the prevalence of ESBL genes in other bacteria, in
other healthy cows, or in cows with subclinical mastitis which
is usually 30–40% higher than clinical mastitis (Halasa et al.,
2007).We presume that the actual prevalence of ESBL-producers,
particularly E. coli, may be much higher than the reported.
In ESBL-positive E. coli, phylogenetic group A represented
the most prevalent group followed by virulent extra-intestinal
group D; however, this was in contrast to our previous
study (Liu et al., 2014), which reported that the pathogenic
E. coli associated with mastitis mainly belonged to phylo-
group B1 (58.6%) rather than group A (35.7%). Nevertheless,
similar phylogenetic distributions were observed in some ESBL-
producing E. coli isolated from animals (Abraham et al., 2014;
Xu et al., 2015). Our results indicated that all the ESBL-
producing E. coli isolates were MDR. The majority of these
isolates (54–100%) were found resistant to cephalosporins.
In addition, low susceptibility was also observed against
the common β-lactam and non-β-lactam antibiotics such as
ampicillin, aminoglycosides, tetracycline and fluoroquinolones.
Recently, many studies have reported MDR ESBL-producing
E. coli isolated from cattle (Timofte et al., 2014), poultry (Kar
et al., 2015), pigs (Xu et al., 2015), and humans (Gu et al.,
2008). Fluoroquinolones, following ciprofloxacin, are the second
important antimicrobial drug in veterinary and human medicine
(Coque et al., 2008). Quinolone resistance is traditionally caused
by chromosomal mutations in gyrase or topoisomerase encoding
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genes or eﬄux pump expression regulating genes (Hopkins et al.,
2005); nonetheless, plasmid mediated quinolone resistance is
also increasingly reported in ESBL-producing E. coli (Xu et al.,
2015).
Integrons play an important role in the emergence of MDR
bacteria and in the dissemination of resistance genes. Published
reports on the characterization of integrons in ESBLs-positive E.
coli from dairy cows are scarce, but previous studies have been
conducted in other food-animals, humans and the environment
(Gu et al., 2008; Chen et al., 2010; Xu et al., 2015). In
accordance to these studies, clinical class 1 integrons were found
in the majority of ESBL-positive E. coli (83.33%). The gene
cassette arrays of the class 1 integron variable regions contained
five different gene combinations that likely impart additional
resistance features to our isolates (see Table 3). Six of the intI1
positive amplicons were failed to generate gene cassettes which
may be related to the absence of 3′CS in these integrons (Lu
et al., 2010). The dfrA17-aadA5 was the predominant gene array
that corroborates with the previous studies in China (Gu et al.,
2008; Xu et al., 2015). Strikingly, we determined that majority
of blaCTX-M genes were associated with ISCR1 elements, but
no ESBL genes were found in the class 1 integron cassettes.
It agrees with other published reports that also did not detect
ESBL genes in the cassettes (Kiiru et al., 2013; Kar et al.,
2015; Xu et al., 2015). Notably, our findings of the most pre-
dominant CTX-M type (blaCTXM-15) and its association with the
ISCR1 elements rather than gene cassette arrays indicated that
they are more likely mobilized by ISCR1 elements. Conversely,
blaTEM, when found alone or not associated with blaCTXM-15,
was not often found linked to ISCR1, and therefore, was
comparatively less prevalent. It has been proposed that antibiotic
resistance gene elements are added to the 3′-CS of class 1
integrons by co-mobilization with the nearby ISCR1 from the
neighbor integron, implying rolling circle transposition and
homologous recombination mechanisms, thus facilitating the
formation of complex class 1 integrons (Toleman et al., 2006).
Taken together, the current high occurrence of multi-resistant
ESBL-producing E. coli carrying clinical class 1 integrons and
its association with ISCR1 is worrisome. This may suggest
these bacteria are armouring against the antibiotics by devising
various tools to render antibiotics useless. Fear exists that this
co-existence of ESBL genes along with class 1 integrons as
gene cassettes and ISCR1 mobile elements would more robustly
disseminate resistance elements within bacterial populations.
This calls for an efficient control policy with restriction on the
consumption of extended spectrum cephalosporins for long term
use.
CONCLUSIONS
Here, we report on the high occurrence of ESBL-producing
E. coli from bovinemastitis. Genotypic characterization indicated
a dominance of blaCTX-M-15 genes harboring clinical class 1
integrons associated with ISCR1 elements, indicative rapid and
wider dissemination potential and posing threats to veterinary
and public health. To the best of our knowledge, this is the first
comprehensive study to report on the alarming high prevalence
of blaCTX-M-15 and class 1 integron resistance conferring
elements in ESBL-producing E. coli from mastitic cows in
China.
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